Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lenz

Showing results (351-360 of 367) with videos related to

Pageof 37
Sort By:
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 11, 2016
Right atrial lead fixation type and lead position are associated with significant variation in complicationsChance M Witt, Charles J Lenz, Henry H Shih, et al.
Journal of Cardiovascular Electrophysiology|May 26, 2017
Right ventricular pacemaker lead position is associated with differences in long-term outcomes and complicationsChance M Witt, Charles J Lenz, Henry H Shih, et al.
Journal of Thrombosis and Haemostasis : JTH|October 21, 2019
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trialRobert D McBane, Waldemar E Wysokinski, Jennifer G Le-Rademacher, et al.
The Pharmacogenomics Journal|December 23, 2015
Genetic variants associated with colorectal brain metastases susceptibility and survivalS Stremitzer, A S Berghoff, N B Volz, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Assessment of MYC Gene and WNT Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic/Latino Patients Using Integrated Multi-Omics ApproachesF G Carranza, B Waldrup, Y Jin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2022
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142T André, S Lonardi, K Y M Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumorsS J Wong, T Karrison, D N Hayes, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Pageof 37

Showing results (351-360 of 367) with videos related to

Sort By:
Pageof 37
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 11, 2016
Right atrial lead fixation type and lead position are associated with significant variation in complicationsChance M Witt, Charles J Lenz, Henry H Shih, et al.
Journal of Cardiovascular Electrophysiology|May 26, 2017
Right ventricular pacemaker lead position is associated with differences in long-term outcomes and complicationsChance M Witt, Charles J Lenz, Henry H Shih, et al.
Journal of Thrombosis and Haemostasis : JTH|October 21, 2019
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trialRobert D McBane, Waldemar E Wysokinski, Jennifer G Le-Rademacher, et al.
The Pharmacogenomics Journal|December 23, 2015
Genetic variants associated with colorectal brain metastases susceptibility and survivalS Stremitzer, A S Berghoff, N B Volz, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Assessment of MYC Gene and WNT Pathway Alterations in Early-Onset Colorectal Cancer Among Hispanic/Latino Patients Using Integrated Multi-Omics ApproachesF G Carranza, B Waldrup, Y Jin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2022
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142T André, S Lonardi, K Y M Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.
British Journal of Cancer|October 29, 2014
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumorsM Koczywas, P H Frankel, T W Synold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumorsS J Wong, T Karrison, D N Hayes, et al.
ESMO Gastrointestinal Oncology|April 23, 2026
Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancerM Fakih, S Gill, K Sampat, et al.
Pageof 37